biotech.today
All Modalities
PlatformEarly Stage

Organ-on-Chip / Microphysiology

Microfluidic devices that simulate human organ function for drug testing, reducing reliance on animal models. The FDA Modernization Act 2.0 has accelerated adoption of these alternative testing platforms.

Key Companies

EmulateCN BioHesperosJavelin Biotech

Recent Signals

REGULATORY

Organ-on-Chip Adoption Accelerates Under FDA Modernization Act 2.0

Two years after the legislation allowing non-animal testing methods, microphysiology systems are seeing real adoption in IND-enabling studies. Three pharma companies report replacing animal tox studies with organ chips.

Apr 8, 2026 · 6 min read